Chelerythrine increases Na-K-ATPase activity and limits ischemic injury in isolated rat hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  Lundmark, Jennifer L ^a   Ramasamy, Ravichandran ^a   Vulliet, P Richard ^b   Schaefer, Saul ^a  

^a WF Goodman Center for Comparative Medical Genetics School of Veterinary Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardioprotection; Intracellular sodium; Protein kinase C

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHELERYTHRINE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT; SODIUM CELL LEVEL; SODIUM TRANSPORT;

EID: 0032885623     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.3.h999     Document Type: Article

References (47)

1. Anderson, S. E., E. Murphy, C. Steenbergen, R. E. London, and P. M. Cala. Na/H exchange in myocardium: effects of hypoxia and acidification on Na and Ca. Am. J. Physiol. 259 (Cell Physiol. 28): C940-C948, 1990.
2. Armstrong, S., J. M. Downey, and C. E. Ganote. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc. Res. 28: 72-77, 1994.
3. +-ATPase activity in regionally ischemic rat hearts. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H957-H964, 1996.
4. +-ATPase inhibits the activity of the enzyme. Proc. Natl. Acad. Sci. USA 88: 11359-11362, 1991.
5. Bertorello, A. M., and A. I. Katz. Short-term regulation of renal Na-K-ATPase activity: physiological relevance and cellular mechanisms. Am. J. Pathol. 265: F743-F755, 1993.
6. 3 and metabolic inhibitors. J. Gen. Physiol. 67: 91-112, 1976.
7. Bradford, M. M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
8. Bugge, E., and K. Ytrehus. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of a adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc. Res. 29: 401-406, 1995.
9. Cave, A. C., and C. S. Apstein. Polymixin B, a protein kinase inhibitor, abolishes preconditioning-induced protection against contractile dysfunction in the isolated blood perfused rat heart. J. Mol. Cell. Cardiol. 28: 977-987, 1996.
10. Chen, W., W. Wetsel, C. Steenbergen, and E. Murphy. Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. J. Mol. Cell. Cardiol. 28: 871-880, 1996.
11. Chibalin, A. V., L. A. Vasilets, H. Hennekes, D. Pralong, and K. Geering. Phosphorylation of Na-K-ATPase α-subunits in microsomes and in homogenates of Xenopus oocytes resulting from the stimulation of protein kinase A and protein kinase C. J. Biol. Chem. 267: 22378-22384, 1992.
12. 87Rb NMR spectroscopic study. Magn. Reson. Med. 34: 673-685, 1995.
13. De Albuquerque, C. P., G. Gerstenblith, and R. G. Weiss. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ. Res. 74: 139-150, 1994.
14. Dennis, S. C., W. Gevers, and L. H. Opie. Protons in ischemia: where do they come from, where do they go to? J. Mol. Cell. Cardiol. 23: 1077-1086, 1991.
15. +-ATPase in rat proximal convoluted tubules. Am. J. Physiol. 268 (Cell Physiol. 37): C1277-C1288, 1995.
16. + exchange. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H289-H298, 1993.
17. Gray, M. O., J. S. Karliner, and D. Mochly-Rosen. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxis-induced cell death. J. Biol. Chem. 272: 30945-30951, 1997.
18. Grinwald, P. M. Sodium pump failure in hypoxia and reoxygenation. J. Mol. Cell. Cardiol. 24: 1393-1398, 1992.
19. 2+ exchange. Circ. Res. 71: 547-557, 1992.
20. Herbert, J. M., J. M. Augereau, J. Gleye, and J. P. Maffrand. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172: 993-999, 1990.
21. Inoguchi, T., R. Battan, E. Handler, J. R. Sportsman, W. Heath, and G. L. King. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. USA 89: 11059-11063, 1992.
22. Kida, M., H. Fujiwara, M. Ishida, C. Kawai, M. Ohura, I. Miura, and Y. Yabuuchi. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 84: 2495-2503, 1991.
23. Lasley, R. D., M. A. Noble, and R. M. J. Mentzer. Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium. J. Mol. Cell. Cardiol. 29: 3345-3356, 1997.
24. 3H] ouabain binding sites in sarcolemma prepared from hearts of spontaneously hypertensive rats. Hypertension 5: 682-688, 1983.
25. Liu, Y., K. Ytrehus, and J. M. Downey. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J. Mol. Cell. Cardiol. 26: 661-668, 1994.
26. Lundmark, J. A., N. Trueblood, L. F. Wang, R. Ramasamy, and S. Schaefer. Repetitive acidosis protects the ischemic heart: implications for mechanisms in preconditioned hearts. J. Mol. Cell. Cardiol. 31: 907-917, 1999.
27. Malloy, C. R., D. G. Buster, M. M. C. A. Castro, C. F. G. C. Geraldes, F. M. H. Jeffrey, and A. D. Sherry. Influence of global ischemia on intracellular sodium in the perfused rat heart. Magn. Reson. Med. 15: 33-44, 1990.
28. Mitchell, M. B., X. Meng, L. Ao, J. M. Brown, A. H. Harken, and A. Banerjee. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76: 73-81, 1995.
29. Miyata, H., E. G. Lakatta, M. D. Stern, and H. S. Silverman. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ. Res. 71: 605-613, 1992.
30. Murry, C. E., V. J. Richard, K. A. Reimer, and R. B. Jennings. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66: 913-931, 1990.
31. +-ATPase activity reduces the infarct size-limiting effect of preconditioning in rabbit hearts. Circulation 96: 599-604, 1997.
32. 2+ and protein kinase C. J. Biol. Chem. 266: 11559-11566, 1991.
33. + exchange. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H2017-H2026, 1989.
34. Ramasamy, R., H. Liu, J. L. Lundmark, S. Anderson, and S. Schaefer. Ischemic preconditioning stimulates sodium and proton transport in the isolated rat heart. J. Clin. Invest. 96: 1464-1472, 1995.
35. 31P-NMR study. J. Mol. Cell. Cardiol. 25: 1403-1411, 1993.
36. Schaefer, S., L. J. Carr, E. Prussel, and R. Ramasamy. Effects of glycogen depletion on ischemic injury in the isolated rat heart: insights into preconditioning. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H935-H944, 1995.
37. Schaefer, S., H. Liu, and R. Ramasamy. Effect of substrate on intracellular sodium kinetics with global myocardial ischemia. Soc. Magn. Reson. Med.: 1635, 1995.
38. Scharschmidt, B. F., E. B. Keeffe, N. M. Blankenship, and R. K. Ochner. Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and Na,K-ATPase activity. J. Lab. Clin. Med. 93: 790-799, 1979.
39. Scholz, W., and U. Albus. Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy. Cardiovasc. Res. 29: 184-188, 1995.
40. + exchange inhibitors in cardiac ischemia. J. Mol. Cell. Cardiol. 24: 731-740, 1992.
41. Shahedi, M., K. LaBorde, L. Bussieres, M. Dechaux, and C. Sachs. Protein kinase C activation causes inhibition of Na/K ATPase activity in Madin-Darby canine kidney epithelial (MDCK) cells. Pflügers Arch. 420: 269-274, 1992.
42. Speechly-Dick, M. E., M. M. Mocanu, and D. M. Yellon. Protein kinase C: its role in ischemic preconditioning in the rat. Circ. Res. 75: 586-590, 1994.
43. Steenbergen, C., E. Murphy, J. A. Watts, and R. E. London. Correlation between cystolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ. Res. 66: 135-146, 1990.
44. Symons, J. D., S. D. Correa, and S. Schaefer. Na-H exchange inhibition with cariporide limits functional impairment due to repetitive ischemia. J. Cardiovasc. Pharmacol. 32: 853-862, 1998.
45. Vogt, A., P. Htun, M. Arras, T. Podzuweit, and W. Shaper. Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res. Cardiol. 91: 389-400, 1996.
46. +-adensoine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J. Clin. Invest. 96: 733-740, 1995.
47. Ytrehus, K., Y. Liu, and J. M. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.